Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 37.00 | |
5 mg | In stock | $ 57.00 | |
10 mg | In stock | $ 106.00 | |
25 mg | In stock | $ 208.00 | |
50 mg | In stock | Inquiry | |
1 mL * 10 mM (in DMSO) | In stock | $ 57.00 |
Description | PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM. |
Targets&IC50 | DGAT-1:19 nM |
In vitro | Ampiroxicam (<150 μM) dose-dependently decreases the proliferation of Panc-1 cells. [1] Ampiroxicam (50 μM) results in decreased expression of Sp1, Sp3, Sp4, and VEGFR1 proteins in Panc-1 cells and L3.6pl cells as determined by Western blot analysis. Ampiroxicam (50 μM) results in increased phosphorylation of MAPK1/2 in Panc-1 cells and L3.6pl cells. [2] |
In vivo | In Rats, PF-04620110 reduces plasma triglyceride levels t doses of ≥0.1 mg/kg following a lipid challenge. [1] DGAT1 inhibition by PF-04620110 causes an enrichment of polyunsaturated fatty acids within the TG class of lipids in rodents. [2] |
Synonyms | PF04620110, PF 04620110 |
Molecular Weight | 396.44 |
Formula | C21H24N4O4 |
CAS No. | 1109276-89-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.9 mg/mL (20 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PF-04620110 1109276-89-2 Metabolism Acyltransferase Transferase acyl-CoA:cholesterol acyltransferase mono- acylglycerol acyltransferase PF04620110 Diacylglycerol acyltransferase Diglyceride acyltransferase PF 04620110 Inhibitor inhibit inhibitor